» Articles » PMID: 35054959

Synergetic Fermentation of Glucose and Glycerol for High-Yield N-Acetylglucosamine Production in

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jan 21
PMID 35054959
Authors
Affiliations
Soon will be listed here.
Abstract

N-acetylglucosamine (GlcNAc) is an amino sugar that has been widely used in the nutraceutical and pharmaceutical industries. Recently, microbial production of GlcNAc has been developed. One major challenge for efficient biosynthesis of GlcNAc is to achieve appropriate carbon flux distribution between growth and production. Here, a synergistic substrate co-utilization strategy was used to address this challenge. Specifically, glycerol was utilized to support cell growth and generate glutamine and acetyl-CoA, which are amino and acetyl donors, respectively, for GlcNAc biosynthesis, while glucose was retained for GlcNAc production. Thanks to deletion of the 6-phosphofructokinase (PfkA and PfkB) and glucose-6-phosphate dehydrogenase (ZWF) genes, the main glucose catabolism pathways of were blocked. The resultant mutant showed a severe defect in glucose consumption. Then, the GlcNAc production module containing glucosamine-6-phosphate synthase (GlmS*), glucosamine-6-phosphate N-acetyltransferase (GNA1*) and GlcNAc-6-phosphate phosphatase (YqaB) expression cassettes was introduced into the mutant, to drive the carbon flux from glucose to GlcNAc. Furthermore, co-utilization of glucose and glycerol was achieved by overexpression of glycerol kinase (GlpK) gene. Using the optimized fermentation medium, the final strain produced GlcNAc with a high stoichiometric yield of 0.64 mol/mol glucose. This study offers a promising strategy to address the challenge of distributing carbon flux in GlcNAc production.

Citing Articles

Production of -acetylglucosamine with FA2, an emerging platform for economical unsterile open fermentation.

Peng Y, Xu P, Tao F Synth Syst Biotechnol. 2023; 8(3):546-554.

PMID: 37637200 PMC: 10457514. DOI: 10.1016/j.synbio.2023.08.003.


Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis.

Shumyatsky G, Burrell A, Chaney H, Sami I, Koumbourlis A, Freishtat R Front Med (Lausanne). 2023; 9:1082125.

PMID: 36698799 PMC: 9868313. DOI: 10.3389/fmed.2022.1082125.


Metabolic Engineering of for High-Level Production of Salicin.

Zhang M, Liu C, Xi D, Bi H, Cui Z, Zhuang Y ACS Omega. 2022; 7(37):33147-33155.

PMID: 36157746 PMC: 9494424. DOI: 10.1021/acsomega.2c03347.


Metabolically Engineered for Conversion of D-Fructose to D-Allulose Phosphorylation-Dephosphorylation.

Guo Q, Liu C, Zheng L, Zheng S, Zhang Y, Zhao S Front Bioeng Biotechnol. 2022; 10:947469.

PMID: 35814008 PMC: 9257026. DOI: 10.3389/fbioe.2022.947469.

References
1.
Niu T, Lv X, Liu Y, Li J, Du G, Ledesma-Amaro R . The elucidation of phosphosugar stress response in Bacillus subtilis guides strain engineering for high N-acetylglucosamine production. Biotechnol Bioeng. 2020; 118(1):383-396. DOI: 10.1002/bit.27577. View

2.
Niyas A, Eiteman M . Phosphatases and phosphate affect the formation of glucose from pentoses in . Eng Life Sci. 2020; 17(5):579-584. PMC: 6999600. DOI: 10.1002/elsc.201600177. View

3.
Kumari S, Beatty C, Browning D, Busby S, Simel E, Wolfe A . Regulation of acetyl coenzyme A synthetase in Escherichia coli. J Bacteriol. 2000; 182(15):4173-9. PMC: 101899. DOI: 10.1128/JB.182.15.4173-4179.2000. View

4.
Ahmad S, Ahmad R, Khan M, Kant R, Shahid S, Gautam L . Chitin and its derivatives: Structural properties and biomedical applications. Int J Biol Macromol. 2020; 164:526-539. DOI: 10.1016/j.ijbiomac.2020.07.098. View

5.
You R, Wang L, Shi C, Chen H, Zhang S, Hu M . Efficient production of myo-inositol in Escherichia coli through metabolic engineering. Microb Cell Fact. 2020; 19(1):109. PMC: 7247202. DOI: 10.1186/s12934-020-01366-5. View